Pausing the pills: attitudes to treatment interruption
Participants in HIV cure trials will increasingly need to consider stopping antiretroviral treatment. This will be the only sure way to know if a cure strategy really works. In the U=U era, when HIV...
INSPIRE: community engagement and cure at IAS2019
What is the INSPIRE project? HIV cure research doesn’t happen in a bubble. The bodies and lives of people living with HIV are impacted by research. The whole process needs community input and...T follicular helper REServoir in AXillary lymph nodes (TRESAX) study
Study type Summary Inclusion Criteria Participation requirements Status Observational study The TRESAX study aims to better understand the contribution that CD4 T follicular helper cells make to the...Abbvie M19-939 (budigalimab phase 1 study)
Study type Summary Inclusion Criteria Participation requirements Status Randomised placebo-controlled study Phase 2 of this international study is being conducted in Melbourne. Participants will...
Read the Winter Issue of Positive Living Here
In the winter issue of Positive Living we’ve four takeaways from CROI — plus why talk of a cure is premature. In an era of U=U and TasP, we ask: are the long-term survivors the forgotten...TITAN study
Study type Summary Inclusion Criteria Participation requirements Status Randomised placebo-controlled study The TITAN study is investigating the effect of three drugs on the latent HIV reservoir and...
Women and cure in the U=U era
Undetectable equals Untransmittable. Three powerful words that have come to symbolise a transformative development in HIV treatment. From the fear and stigma of the early days of the HIV epidemic and...NIVO-LD
Study type Summary Inclusion Criteria Participation requirements Status 2 phase study. Phase 1: dose finding study Phase 2: Randomised placebo controlled study The NIVO-LD study is...
.png)